Fundraising FoxSyfovre
1 known investors
Find your way into Syfovre
Sign up to see every warm intro you have to Syfovre
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Syfovre team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SYFOVRE is a prescription treatment shown to slow the progression of geographic atrophy (GA), the advanced form of dry age-related macular degeneration that affects the retina. It is administered via periodic doses (once every 25-60 days) as determined by a physician.
Investors · 1
Frequently asked questions
- What does Syfovre do?
- SYFOVRE is a prescription treatment shown to slow the progression of geographic atrophy (GA), the advanced form of dry age-related macular degeneration that affects the retina. It is administered via periodic doses (once every 25-60 days) as determined by a physician.
- Who are Syfovre's investors?
- Syfovre's investors include DRI Healthcare.